Study of the Clinical Management of Bipolar Disease (WAVE bd)
Multinational Ambispective Study of the Clinical Management and Burden of Bipolar Disorder (WAVE bd Study)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Salzburg, Austria
- Research Site
-
Villach, Austria
- Research Site
-
Vocklabruck, Austria
- Research Site
-
Wien, Austria
- Research Site
-
Wr. Neustadt, Austria
- Research Site
-
-
-
-
-
Asse, Belgium
- Research Site
-
Begijnendijk, Belgium
- Research Site
-
Berchem, Belgium
- Research Site
-
Bredene, Belgium
- Research Site
-
Brugge, Belgium
- Research Site
-
Bruxelles, Belgium
- Research Site
-
Elsene, Belgium
- Research Site
-
Herstal, Belgium
- Research Site
-
Houtvenne, Belgium
- Research Site
-
Jette, Belgium
- Research Site
-
Keumiee, Belgium
- Research Site
-
Kontich, Belgium
- Research Site
-
Kuringen, Belgium
- Research Site
-
Lebbeke, Belgium
- Research Site
-
Lede, Belgium
- Research Site
-
Lembeke, Belgium
- Research Site
-
Leuven, Belgium
- Research Site
-
Liege, Belgium
- Research Site
-
Lubbeek, Belgium
- Research Site
-
Maldegem, Belgium
- Research Site
-
Mechelen, Belgium
- Research Site
-
Mol, Belgium
- Research Site
-
Monceau-Sur-Sambre, Belgium
- Research Site
-
Montignies-Sur-Sambre, Belgium
- Research Site
-
Moorsel, Belgium
- Research Site
-
Namur, Belgium
- Research Site
-
Oosteeklo, Belgium
- Research Site
-
Oostrozebeke, Belgium
- Research Site
-
Ottignies, Belgium
- Research Site
-
Pittem, Belgium
- Research Site
-
Ransart, Belgium
- Research Site
-
Roeselare, Belgium
- Research Site
-
Roux, Belgium
- Research Site
-
Saint-Servais, Belgium
- Research Site
-
Sint-Denijs-Westrem, Belgium
- Research Site
-
Sint-Kruis, Belgium
- Research Site
-
Sint-Martens-Latem, Belgium
- Research Site
-
Sint-Niklaas, Belgium
- Research Site
-
Sint-Truiden, Belgium
- Research Site
-
Spouwen, Belgium
- Research Site
-
Tienen, Belgium
- Research Site
-
Tournai, Belgium
- Research Site
-
Veurne, Belgium
- Research Site
-
Wezembeek-oppem, Belgium
- Research Site
-
Willebroek, Belgium
- Research Site
-
Wilrijk, Belgium
- Research Site
-
Zeebrugge, Belgium
- Research Site
-
Zoersel, Belgium
- Research Site
-
Zomergem, Belgium
- Research Site
-
-
-
-
-
Aparecida de Goiania, Brazil
- Research Site
-
Belo Horizonte, Brazil
- Research Site
-
Botucatu, Brazil
- Research Site
-
Campinas, Brazil
- Research Site
-
Fortaleza, Brazil
- Research Site
-
Goiania, Brazil
- Research Site
-
Itapira, Brazil
- Research Site
-
Rio de Janeiro, Brazil
- Research Site
-
Salvador, Brazil
- Research Site
-
Santo Andre, Brazil
- Research Site
-
Sao Bernardo, Brazil
- Research Site
-
Sao Jose, Brazil
- Research Site
-
Sao Paulo, Brazil
- Research Site
-
-
-
-
-
Ajaccio, France
- Research Site
-
Albi, France
- Research Site
-
Alencon Cedex, France
- Research Site
-
Amiens, France
- Research Site
-
Appoigny, France
- Research Site
-
Armentieres, France
- Research Site
-
Aulnay Sous Bois, France
- Research Site
-
Bar Le Duc, France
- Research Site
-
Belfort, France
- Research Site
-
Bergerac, France
- Research Site
-
Besancon, France
- Research Site
-
Blois, France
- Research Site
-
Bordeaux, France
- Research Site
-
Bourg En Bresse, France
- Research Site
-
Bourges, France
- Research Site
-
Brest, France
- Research Site
-
Caen Cedex 1, France
- Research Site
-
Castries, France
- Research Site
-
Clermmont Ferrand, France
- Research Site
-
Creteil Cedex, France
- Research Site
-
Dijon, France
- Research Site
-
Douai, France
- Research Site
-
Elancourt, France
- Research Site
-
Esquerchin, France
- Research Site
-
Fains Veel, France
- Research Site
-
Frejus Cedex, France
- Research Site
-
GAP, France
- Research Site
-
Grenoble, France
- Research Site
-
Hauteville Lompnes, France
- Research Site
-
Hyeres, France
- Research Site
-
Jarnac, France
- Research Site
-
La Charite Sur Loire, France
- Research Site
-
La Roche Sur Foron, France
- Research Site
-
La Rochelle, France
- Research Site
-
Lavaur, France
- Research Site
-
Le Cannet, France
- Research Site
-
Le Havre, France
- Research Site
-
Le Puy En Velay, France
- Research Site
-
Le Vesinet, France
- Research Site
-
Libourne, France
- Research Site
-
Lorient, France
- Research Site
-
Marseille, France
- Research Site
-
Mayenne Cedex, France
- Research Site
-
Metz, France
- Research Site
-
Mont de Marsan, France
- Research Site
-
Montberon, France
- Research Site
-
Montpellier, France
- Research Site
-
Montreuil, France
- Research Site
-
Mulhouse, France
- Research Site
-
Nancy, France
- Research Site
-
Nanterre, France
- Research Site
-
Nantes, France
- Research Site
-
Neuilly Sur Marne, France
- Research Site
-
Nice, France
- Research Site
-
Orsay, France
- Research Site
-
PAU, France
- Research Site
-
Paris, France
- Research Site
-
Reims, France
- Research Site
-
Rennes, France
- Research Site
-
Rodez, France
- Research Site
-
Sartrouville, France
- Research Site
-
St Avertin, France
- Research Site
-
St Brieuc, France
- Research Site
-
St Dizier, France
- Research Site
-
St Gratien, France
- Research Site
-
St Herblain, France
- Research Site
-
St Nazaire, France
- Research Site
-
St Pol Sur Ternoise, France
- Research Site
-
St Quentin, France
- Research Site
-
Strasbourg, France
- Research Site
-
Thionville Cedex, France
- Research Site
-
Thuir Cedex, France
- Research Site
-
Toulouse, France
- Research Site
-
Tours, France
- Research Site
-
Vendome, France
- Research Site
-
Versailles, France
- Research Site
-
Wattignies, France
- Research Site
-
-
-
-
-
Berlin, Germany
- Research Site
-
Cham, Germany
- Research Site
-
Dillingen, Germany
- Research Site
-
Ettlingen, Germany
- Research Site
-
Greifswald, Germany
- Research Site
-
Grunstadt, Germany
- Research Site
-
Hildesheim, Germany
- Research Site
-
Karlstadt, Germany
- Research Site
-
Kiel, Germany
- Research Site
-
Luneburg, Germany
- Research Site
-
Munchen, Germany
- Research Site
-
Regensburg, Germany
- Research Site
-
Stralsund, Germany
- Research Site
-
Werneck, Germany
- Research Site
-
Westerstede, Germany
- Research Site
-
-
-
-
-
Angra do Heroismo, Portugal
- Research Site
-
Aveiro, Portugal
- Research Site
-
Braga, Portugal
- Research Site
-
Carnaxide, Portugal
- Research Site
-
Coimbra, Portugal
- Research Site
-
Faro, Portugal
- Research Site
-
Lisboa, Portugal
- Research Site
-
Portimao, Portugal
- Research Site
-
Porto, Portugal
- Research Site
-
Setubal, Portugal
- Research Site
-
Tomar, Portugal
- Research Site
-
-
-
-
-
Bucuresti, Romania
- Research Site
-
Cluj, Romania
- Research Site
-
Craiova, Romania
- Research Site
-
Iasi, Romania
- Research Site
-
-
-
-
-
Ankara, Turkey
- Research Site
-
Antalya, Turkey
- Research Site
-
Aydin, Turkey
- Research Site
-
Basoglu, Turkey
- Research Site
-
Bolu, Turkey
- Research Site
-
Bursa, Turkey
- Research Site
-
Cankiri, Turkey
- Research Site
-
D.bakir, Turkey
- Research Site
-
Denizli, Turkey
- Research Site
-
Diyarbakir, Turkey
- Research Site
-
Elazig, Turkey
- Research Site
-
Eskisehir, Turkey
- Research Site
-
Hatay, Turkey
- Research Site
-
Istanbul, Turkey
- Research Site
-
Izmir, Turkey
- Research Site
-
Kocaeli, Turkey
- Research Site
-
Manisa, Turkey
- Research Site
-
S.urfa, Turkey
- Research Site
-
Samsun, Turkey
- Research Site
-
Sanliurfa, Turkey
- Research Site
-
Sivas, Turkey
- Research Site
-
Tahsin, Turkey
- Research Site
-
Tugay, Turkey
- Research Site
-
Zonguldak, Turkey
- Research Site
-
-
-
-
-
Dnipropetrovsk, Ukraine
- Research Site
-
Donetsk, Ukraine
- Research Site
-
Ivano-Frankivsk, Ukraine
- Research Site
-
Kharkiv, Ukraine
- Research Site
-
Kiev, Ukraine
- Research Site
-
Lugansk, Ukraine
- Research Site
-
Lviv, Ukraine
- Research Site
-
Odessa, Ukraine
- Research Site
-
Simferopol, Ukraine
- Research Site
-
Vinnitsa, Ukraine
- Research Site
-
Zaporizhzhya, Ukraine
- Research Site
-
-
-
-
-
Caracas, Venezuela
- Research Site
-
Merida, Venezuela
- Research Site
-
Miranda, Venezuela
- Research Site
-
San Cristobal, Venezuela
- Research Site
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of Bipolar Disorder I or II (DSM-IV TR) in any phase of the disorder
- Patients who had at least one mood event (depression, mania, hypomania or mixed) according to DSM-IV TR definition during the 12 months prior to the beginning of the study
Exclusion Criteria:
- Patients who had the index mood event during the 3 months before the beginning of the study (Time 0).
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
1
Patients diagnosed with Bipolar Disorder I or II (DSM-IV-TR) at any phase of the disorder with at least one mood event during the 12 months before the study start.
|
|
2
Patients diagnosed with Bipolar Disorder I or II (DSM-IV-TR) at any phase of the disorder with at least one mood event during the 12 months before the study start receiving Seroquel extended release at some point during the retrospective period .
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Demographic variables
Time Frame: Once during study
|
Once during study
|
|
1-year prevalence for each disease phase
Time Frame: everytime the patient attends the consult
|
everytime the patient attends the consult
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Use of resources
Time Frame: everytime the patient attends the consult
|
everytime the patient attends the consult
|
|
treatments prescribed, EQ5D
Time Frame: everytime the patient attends the consult
|
everytime the patient attends the consult
|
|
treatments prescribed, FAST
Time Frame: everytime the patient attends the consult
|
everytime the patient attends the consult
|
|
treatments prescribed, DAI-10
Time Frame: everytime the patient attends the consult
|
everytime the patient attends the consult
|
|
treatments prescribed, MPR
Time Frame: everytime the patient attends the consult
|
everytime the patient attends the consult
|
|
treatments prescribed, BAS
Time Frame: Once during the prospective part (only if patient attends with a caregiver)
|
Once during the prospective part (only if patient attends with a caregiver)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Esteban Medina, Medical Department.AstraZeneca Spain
Publications and helpful links
General Publications
- Vieta E, Langosch JM, Figueira ML, Souery D, Blasco-Colmenares E, Medina E, Moreno-Manzanaro M, Gonzalez MA, Bellivier F. Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd). Int J Neuropsychopharmacol. 2013 Sep;16(8):1719-32. doi: 10.1017/S1461145713000278. Epub 2013 May 13.
- Vieta E, Blasco-Colmenares E, Figueira ML, Langosch JM, Moreno-Manzanaro M, Medina E; WAVE-bd Study Group. Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study). BMC Psychiatry. 2011 Apr 11;11:58. doi: 10.1186/1471-244X-11-58.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NIS-NEU-DUM-2009/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.